Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along intrahepatic biliary tree

Laboratory Investigation

Volumn 80, Issue 7, 2000, Pages 1007-1017

  Koda, Wataru ^a   Harada, Kenichi ^a   Tsuneyama, Koichi ^a   Kono, Naoko ^a   Sasaki, Motoko ^a   Matsui, Osamu ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BLOOD FLOW; LIVER CIRCULATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033943277     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780106     Document Type: Article

References (50)

1. Abelmann WH (1991). Hyperdynamic circulation. In: Okuda K and Bnehamou JP, editors. Portal hypertension: Clinical and physiological aspects. Tokyo: Springer-Verlag, 101-113.
2. Akiyoshi H and Terada T (1998). Mast cells, myofibroblasts and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 112-119.
3. Alexander B (1998). The role of nitric oxide in hepatic metabolism. Nutrition 14:376-390.
4. Bauer M, Zhang JX, Bauer I, and Clemens MG (1994). ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action. Am J Physiol 267:G143-G149.
5. Befus D, Fujimaki H, Lee TDG, and Sweiter M (1988). Mast cell polymorphisms. Recent concepts, future directions. Dig Dis Sci 33:S16-S24.
6. Craig SS, Schechtner NM, and Schwartz LB (1988). Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 58:682-691.
7. Crowe SE, Kuthra GK, and Perdue MH (1997). Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut 41:785-792.
8. Enoki H (1998). Statistical analysis by StatView, 5th ed., Tokyo: Kanehara Publishers.
9. Farrell DJ, Jones JE, Walls AF, Kelly PJ, Bennett MK, and Burt AD (1995). Intrahepatic mast cells in chronic liver diseases. Hepatology 22:1175-1181.
10. Feldman MJ, Morris GP, Dinda PK, and Paterson EG (1996). Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 110:121-128.
11. Foreman JC (1987). Neuropeptides and the pathogenesis of allergy. Allergy 42:1-11.
12. Galli SJ (1993). New concepts about the mast cell. N Engl J Med 6:91-97.
13. Gandhi CR, Sproat LA, and Subbotin VM (1996). Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Science 58:55-62.
14. Gondo K, Ueno T, Sakamoto M, Sakisaka S, Sata M, and Tanikawa K (1993). The endothelin-1 binding site in rat liver tissue: Light- and electron-microscopic autoradiographic studies. Gastroenterology 104:1745-1749.
15. Grube D (1980). Immunoreactivities of gastrin (G-) cells. II. Non-specific binding of immunoglobulins to G-cells by ionic interactions. Histochemistry 66:149-167.
16. Housset C, Carayon A, Housset B, Legendre C, Hannoun L, and Pououn R (1993). Endothelin-1 secretion by human gallbladder epithelial cells in primary culture. Lab Invest 69:750-755.
17. Irani AA, Bradford TR, Kepley CL, Schlechter NM, and Schwartz LB (1989). Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509-1515.
18. Kobayashi K, Nakanuma Y, and Matsui O (1994). Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: A histological study. Hum Pathol 25:940-946.
19. Laffi G and Marra F (1999). Complications of cirrhosis: Is endothelium guilty? J Hepatol 30:532-535.
20. Lancaster JR (1994). Stimulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci 91:8137-8147.
21. Leivas A, Jimenez W, Bruix J, Boix L, Bosch J, Arroyo V, Rivera F, and Rodes J (1998). Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: Relationship with hepatic hemodynamics. J Vas Res 35:186-193.
22. Lewis RS, Tamir S, Tannenbaum SR, and Deen WM (1995). Kinetic analysis of the fate of nitric oxide synthase by macrophage in vitro. J Biol Chem 270:29350-29355.
23. Lopez-Talavera JC, Cadelina G, Olchowski J, Merrill W, and Groszman RJ (1996). Thalidomide inhibits tumor necrosis factor, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 23:1616-1621.
24. Luscher TF, Tanner FC, Tschudi MR, and Noll G (1993). Endothelial dysfunction in coronary artery disease. Annu Rev Med 44:395-418.
25. Martini PY, Xu DL, Niederbergen M, Weigert A, Tsai P, St John J, and Schrier RW (1996). Upregulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats. Am J Physiol 270:F494-499.
26. Michielsen PP and Pelckmans PA (1994). Haemodynamic changes in portal hypertension: New insights in the pathogenesis and clinical implications. Acta Gastroenterol Belg 57:194-205
27. Morris SM and Billian TR (1994). New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829-839.
28. Nakanuma Y, Hoso M, Sanzen T, and Sasaki M (1997). Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microscopy Res Tech 38:552-570.
29. Okunishi H, Miyazaki M, and Toda N (1984). Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 2:277-284.
30. Omori M, Omori N, Evarts RP, Teramoto T, and Thorgeirsson SS (1997). Coexpression of flt-3 ligand/flt-3 and SCF/c-kit signal transduction system in bile-duct-ligated SI and W mice. Am J Pathol 150:1179-1187.
31. Pinzani M, Milani S, de Franco R, Grappone C, Caligiuri A, Gentilin A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, and Gentilini P (1996). Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterol 110:534-548.
32. Reilly FD, Dimlich RV, Cilento EV, and MuCuskey RS (1983). Hepatic microvascular regulatory mechanisms. III. Amierngic mechanisms as related to mast cells. Int J Microcirc Clin Exp 2:61-73.
33. Rockey DC, Fouassir L, Chung JJ, Carayan A, Vallee P, Rey C, and Housset C (1998). Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells. Hepatology 27:472-480.
34. Ruck P, Horny HP, and Kaiserling E (1990). Immunoreactivity of human tissue mast cells: Nonspecific binding of primary antibodies against regulatory peptides by ionic linkage. J Histochem Cytochem 38:859-867.
35. Sato Y, Mukai K, Watanabe S, Goto M, and Shimosato Y (1986). The AMeX method: A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immuno-staining. Am J Pathol 125:431-435.
36. Sayama S, lozzo RV, Lazarus GS, and Schechter NM (1987). Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. Biol Chem 262: 6808-6815.
37. Schmidt HW and Walter U (1994). NO at work. Cell 78:719-725.
38. Schrier RW, Arroyo Y, Bernardi M, Epstain M, Henriksen JH, and Rodes J (1988). Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and retention in cirrhosis. Hepatology 8:1151-1157.
39. Shibayama Y (1998). Regulation of hemodynamics of the liver. In: Toda G, Oda M, Kiyosawa K, Tsubouchi H, and Nakanuma Y, editors. Hepatology. Basic Science. Tokyo: Igaku Shoin, 349-355 (Japanese).
40. Sogni P, Moreau R, Gadano A, and Lebrec D (1995). The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol 23:218-224.
41. Sogni P, Smith APL, Gadano A, Lebrec D, and Higenbottam TW (1997). Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis. J Hepatol 26:1120-1127.
42. Suzuki H, Miura S, Liu YY, Tsuchiya M, and Ishii H (1995). Substance P induces degranulation of mast cells and leukocyte adhesion to venular endothelium. Peptides 16:1447-1452.
43. Uchida Y, Ninomiya H, Sakamoto T, Lee JY, Endo T, Nomura A, Hasegawa S, and Hirata F (1992). ET-1 released histamine from guinea pig pulmonary but not peritoneal mast cells. Biochem Biophys Res Commun 189:1196-1201.
44. Vallance P and Moncada S (1991). Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 337:776-778.
45. Wallace JL, McKnight GW, and Gefus AD (1992). Capsaicin-induced hyperemia in the stomach: Possible contribution of mast cells. Am J Physiol 263:G209-G214.
46. Walls AF, Jones DB, Williams JH, Church MK, and Holgate ST (1990). Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol 162:119-126.
47. Weidner N and Austen KF (1990). Evidence of morphologic diversity of human mat cells. An ultrastructural study of mast cells from multiple body sites. Lab Invest 63:63-72.
48. Weidner N and Austen KF (1991). Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. J Invest Dermatol 96:26S-31S.
49. Yamashiro M, Kouda W, Kono N, Tsuneyama K, Matsui O, and Nakanuma Y (1998). Distribution of intrahepatic mast cells in various hepatobiliary disorders: An immunohistochemical study. Virchow Archiv 433:471-479.
50. Yanagisawa M (1994). The endothelin system. A new target for therapeutic intervention. Circulation 89:1320-1322.